SCHEMBL4448012

SCHEMBL4448012

NC(=O)c1c[nH]c2ncc(-c3cccc(F)c3)cc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 7/20 0.58
▸ ITK Q08881 3/20 0.58
▸ CDK2 P24941 2/20 0.58
▸ JAK3 P52333 2/20 0.58
▸ CHEK2 O96017 2/20 0.58
▸ CDC7 O00311 1/20 0.58
▸ PLK4 O00444 1/20 0.58
▸ CHEK1 O14757 1/20 0.58
▸ AURKA O14965 1/20 0.58
▸ MAPK13 O15264 1/20 0.58
▸ PDPK1 O15530 1/20 0.58
▸ DYRK3 O43781 1/20 0.58
▸ ROCK2 O75116 1/20 0.58
▸ RPS6KA5 O75582 1/20 0.58
▸ PRKD3 O94806 1/20 0.58
▸ PAK4 O96013 1/20 0.58
▸ ABL1 P00519 1/20 0.58
▸ EGFR P00533 1/20 0.58
▸ NTRK1 P04629 1/20 0.58
▸ INSR P06213 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20584650 0.87 AXL (0.71) AXLITKCDK2JAK3CHEK2
SCHEMBL2354926 0.86 CYP3A4 (0.53) EGFRKDRNEK2
SCHEMBL13854116 0.85 AXL (0.56) AXLITKCDK2JAK3CHEK2
SCHEMBL13854115 0.82 AXL (0.53) AXLITKCDK2JAK3GSK3A
SCHEMBL3769503 0.82 AXL (0.75) AXLITKCDK2JAK3CHEK2
SCHEMBL13854122 0.82 AXL (0.56) AXLITKCDK2JAK3DYRK1A
SCHEMBL13854106 0.82 RIPK1 (0.56) AXLITKCDK2JAK3CHEK2
SCHEMBL3506669 0.81 AXL (0.58) AXLITKCDK2JAK3CHEK2
SCHEMBL22049462 0.81 AXL (0.42) AXLITKCDK2JAK3CHEK2
SCHEMBL13854104 0.80 ULK1 (0.54) AXLITKCDK2JAK3CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306126-A1 Indole Derivatives ASTRAZENECA AB (SE) 2009-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306126-A1 Indole Derivatives MTOR, IDO1, AKT1S1 AXL 1246/4885ITK 672/4885CDK2 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback